• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

科威特肺结核治疗中断的决定因素。

Determinants of default from pulmonary tuberculosis treatment in Kuwait.

作者信息

Zhang Qing, Gaafer Mohamed, El Bayoumy Ibrahim

机构信息

Tuberculosis Diagnosis and Treatment Center, Shanghai, Pulmonary Hospital, School of Medicine, Tongji University, 507 Zheng Min Road, Shanghai 200433, China.

Community, Environmental and Occupational Medicine Department, Minufiya University, Egypt.

出版信息

ScientificWorldJournal. 2014;2014:672825. doi: 10.1155/2014/672825. Epub 2014 Apr 6.

DOI:10.1155/2014/672825
PMID:24955415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3997844/
Abstract

OBJECTIVES

To determine the prevalence and risk factors of default from pulmonary tuberculosis treatment in Kuwait.

DESIGN

Retrospective study.

PATIENTS AND METHODS

We studied all patients who were registered for pulmonary tuberculosis treatment between January 1, 2010, and December 31, 2012, and admitted into TB wards in El Rashid Center or treated in the outpatient clinic in TB Control Unit.

RESULTS

There were 110 (11.5%) patients who defaulted from treatment. Fifty-six percent of those who defaulted did so in the first 2 months of treatment and 86.4% of them were still bacteriologically positive at the time of default. Key risk factors associated with noncompliance were male sex, low educational level, non-Kuwaiti nations, history of default, and history of concomitant diabetes mellitus, liver disease, or lung cancer. Multiple drug resistance was also associated with default from treatment.

CONCLUSION

Default from treatment may be partially responsible for the persistent relatively high rates of tuberculosis in Kuwait. Health professionals and policy makers should ensure that all barriers to treatment are removed and that incentives are used to encourage treatment compliance.

摘要

目的

确定科威特肺结核治疗中断的患病率及危险因素。

设计

回顾性研究。

患者与方法

我们研究了2010年1月1日至2012年12月31日期间登记接受肺结核治疗并入住拉希德中心结核病病房或在结核病控制单位门诊接受治疗的所有患者。

结果

有110名(11.5%)患者治疗中断。治疗中断的患者中,56%在治疗的前2个月内中断治疗,其中86.4%在中断治疗时仍为细菌学阳性。与不依从相关的关键危险因素包括男性、低教育水平、非科威特国籍、治疗中断史以及合并糖尿病、肝病或肺癌史。多重耐药也与治疗中断有关。

结论

治疗中断可能是科威特结核病持续相对高发的部分原因。卫生专业人员和政策制定者应确保消除所有治疗障碍,并采用激励措施鼓励患者坚持治疗。

相似文献

1
Determinants of default from pulmonary tuberculosis treatment in Kuwait.科威特肺结核治疗中断的决定因素。
ScientificWorldJournal. 2014;2014:672825. doi: 10.1155/2014/672825. Epub 2014 Apr 6.
2
Prevalence and predictors of default from tuberculosis treatment in Hong Kong.香港结核病治疗中断的患病率及预测因素
Hong Kong Med J. 2003 Aug;9(4):263-8.
3
Default from tuberculosis treatment programme in Sagamu, Nigeria.尼日利亚萨加穆结核病治疗项目中的违约情况。
Niger J Med. 2006 Jan-Mar;15(1):63-7. doi: 10.4314/njm.v15i1.37119.
4
Knowledge and perception of tuberculosis and the risk to become treatment default among newly diagnosed pulmonary tuberculosis patients treated in primary health care, East Nusa Tenggara: a retrospective study.东努沙登加拉省初级卫生保健机构中初诊肺结核患者对结核病的认知、看法及治疗中断风险:一项回顾性研究
BMC Res Notes. 2015 Jun 10;8:238. doi: 10.1186/s13104-015-1209-6.
5
Tuberculosis treatment default among Brazilian children.巴西儿童的结核病治疗中断情况。
Int J Tuberc Lung Dis. 2006 Aug;10(8):864-9.
6
Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study.越南未完成治疗的结核病患者的死亡率和治疗失败情况:一项队列研究。
BMC Public Health. 2007 Jul 2;7:134. doi: 10.1186/1471-2458-7-134.
7
Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study.南非 2002 年与结核治疗中断相关的患者和提供者水平风险因素:病例对照研究。
BMC Public Health. 2012 Jan 20;12:56. doi: 10.1186/1471-2458-12-56.
8
Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005.1996 - 2005年科威特结核分枝杆菌分离株药敏模式的长期趋势
Int J Tuberc Lung Dis. 2008 Mar;12(3):319-25.
9
Noncompliance of treatment among tuberculosis patients in intensive phase at Kalutara District of Sri Lanka.斯里兰卡卡卢特勒地区强化期肺结核患者的治疗不依从性。
Indian J Tuberc. 2021 Apr;68(2):266-271. doi: 10.1016/j.ijtb.2020.09.018. Epub 2020 Sep 28.
10
Management outcome of pulmonary tuberculosis: a nine year review in Ilorin.肺结核的管理结果:伊洛林的九年回顾
West Afr J Med. 2003 Jun;22(2):114-9. doi: 10.4314/wajm.v22i2.27928.

引用本文的文献

1
Unmasking the Determinants of Loss to Follow-Up in Pulmonary Tuberculosis: A Study in Selangor, Malaysia.揭示马来西亚雪兰莪州肺结核患者失访的决定因素:一项研究
Trop Med Infect Dis. 2025 Aug 12;10(8):226. doi: 10.3390/tropicalmed10080226.
2
Prevalence, patterns, and determinants of drug-resistant tuberculosis in Gulf Cooperation Council countries: an updated systematic review.海湾合作委员会国家耐多药结核病的患病率、模式及决定因素:一项最新的系统评价
PeerJ. 2024 Nov 28;12:e18628. doi: 10.7717/peerj.18628. eCollection 2024.
3
The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.在艾滋病毒感染者队列中,因结核病治疗失败而中断治疗的患者,随时间推移其 CD4 淋巴细胞轨迹。 ---- 请注意,以上翻译结果仅为示例,具体翻译内容可能因上下文、语境等因素而有所不同。
PLoS One. 2024 Mar 13;19(3):e0299244. doi: 10.1371/journal.pone.0299244. eCollection 2024.
4
Incidence and predictors of treatment interruption among patients on anti-tuberculosis treatment in Nekemte public healthcare facilities, Oromia, Western Ethiopia.埃塞俄比亚西部奥罗米亚州内克姆特公共医疗机构中接受抗结核治疗患者的治疗中断发生率及预测因素
Front Epidemiol. 2023 Dec 4;3:1234865. doi: 10.3389/fepid.2023.1234865. eCollection 2023.
5
Quantifying non-adherence to anti-tuberculosis treatment due to early discontinuation: a systematic literature review of timings to loss to follow-up.量化因早期停药导致的抗结核治疗不依从性:一项关于失访时间的系统文献综述。
BMJ Open Respir Res. 2024 Feb 15;11(1):e001894. doi: 10.1136/bmjresp-2023-001894.
6
T-BACCO SCORE: A predictive scoring tool for tuberculosis (TB) loss to follow-up among TB smokers.T-BACCO 评分:用于预测结核病(TB)吸烟者失访的预测评分工具。
PLoS One. 2023 Jun 15;18(6):e0287374. doi: 10.1371/journal.pone.0287374. eCollection 2023.
7
FACTORS CONTRIBUTING TO PULMONARY TB TREATMENT LOST TO FOLLOW-UP IN DEVELOPING COUNTRIES: AN OVERVIEW.发展中国家肺结核治疗失访的相关因素概述
Afr J Infect Dis. 2022 Dec 22;17(1):60-73. doi: 10.21010/Ajidv17i1.6. eCollection 2023.
8
Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: a systematic review and meta-analysis.亚洲地区结核病治疗中断的流行情况及预测因素:系统评价和荟萃分析。
BMJ Glob Health. 2023 Jan;8(1). doi: 10.1136/bmjgh-2022-010592.
9
Characteristics and determinants of loss to follow-up among tuberculosis (TB) patients who smoke in an industrial state of Malaysia: a registry-based study of the years 2013-2017.马来西亚一工业州吸烟结核病 (TB) 患者失访的特征和决定因素:2013-2017 年基于登记的研究。
BMC Public Health. 2022 Apr 1;22(1):638. doi: 10.1186/s12889-022-13020-3.
10
Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis.预测结核病治疗成功的因素:系统评价与荟萃分析。
PLoS One. 2019 Dec 27;14(12):e0226507. doi: 10.1371/journal.pone.0226507. eCollection 2019.

本文引用的文献

1
XDR tuberculosis--implications for global public health.广泛耐药结核病——对全球公共卫生的影响
N Engl J Med. 2007 Feb 15;356(7):656-9. doi: 10.1056/NEJMp068273.
2
Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.2000 - 2004年全球范围内对二线药物具有广泛耐药性的结核分枝杆菌的出现
MMWR Morb Mortal Wkly Rep. 2006 Mar 24;55(11):301-5.
3
Exploring the determinants of treatment success for tuberculosis cases in Europe.探索欧洲结核病病例治疗成功的决定因素。
Int J Tuberc Lung Dis. 2005 Nov;9(11):1224-9.
4
Tuberculosis treatment outcomes in Europe: a systematic review.欧洲的结核病治疗结果:一项系统评价。
Eur Respir J. 2005 Sep;26(3):503-10. doi: 10.1183/09031936.05.00103504.
5
Treatment outcome of new culture positive pulmonary tuberculosis in Norway.挪威新确诊的痰菌阳性肺结核的治疗结果
BMC Public Health. 2005 Feb 7;5:14. doi: 10.1186/1471-2458-5-14.
6
Current status of treatment completion and fatality among tuberculosis patients in Spain.西班牙结核病患者的治疗完成情况及死亡率现状。
Int J Tuberc Lung Dis. 2004 Apr;8(4):458-64.
7
The management of pulmonary and lymph node tuberculosis notified in England and Wales in 1998.1998年英格兰和威尔士通报的肺结核及淋巴结结核管理情况。
Clin Med (Lond). 2003 Jan-Feb;3(1):57-61. doi: 10.7861/clinmedicine.3-1-57.
8
Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996.1996年瑞士肺结核的治疗结果
Swiss Med Wkly. 2002 Sep 7;132(35-36):517-22. doi: 10.4414/smw.2002.10045.
9
Tuberculosis treatment outcome monitoring: Blackburn 1988-2000.结核病治疗结果监测:布莱克本,1988 - 2000年
Int J Tuberc Lung Dis. 2002 Aug;6(8):662-5.
10
European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group.欧洲低发病率国家结核病控制与消除框架。世界卫生组织(WHO)、国际防痨和肺部疾病联盟(IUATLD)及荷兰皇家结核病协会(KNCV)工作组的建议
Eur Respir J. 2002 Apr;19(4):765-75. doi: 10.1183/09031936.02.00261402.